IL6 and gastroesophageal reflux disease: This activation of the NF-κB pathway is paralleled by a simultaneous increase in interleukin (IL) IL-1β, IL-6, IL-8, and tumor necrosis factor (TNF) along the spectrum of reflux esophagitis, BE, and adenocarcinoma [84–86].